Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

Lactic acid bacteria are one of the bioresources that can promote the host's health and have potential therapeutic applications. This study aimed to evaluate the probiotic properties of novel Lactiplantibacillus plantarum NWAFU-BISO-BS29 isolated in vitro from traditional Chinese fermented milk, assess its safety, and study its interaction with the gut microbiota using a BALB/c mouse model. The findings reveal that this strain had a high tolerance to gastric acidity (64.4%) and bile salts (19.83-87.92%) with remarkable auto-aggregation and co-aggregation abilities (33.01-83.96%), respectively. Furthermore, it lowered the cholesterol levels in dead cells (44.02%) and live cells (34.95%) and produced short-chain fatty acids (SCFAs). Likewise, it showed good antioxidant properties and strong antipathogen activity against Escherichia coli and Staphylococcus aureus with inhibition zones at 21 and 25 mm, respectively. The safety assessment results indicate that all of the virulence factor genes were not detected in the whole DNA; additionally, no hemolysis or resistance to antibiotics commonly used in food and feed was observed. Interestingly, the 16S rRNA gene sequencing of the mouse gut microbiota showed a marked alteration in the microbial composition of the administrated group, with a noticeable increase in Firmicutes, Patescibacteria, Campylobacterota, Deferribacterota, Proteobacteria, and Cyanobacteria at the phylum level. The modulation of gut microbial diversity significantly improved the production of SCFCs due to the abundance of lactobacillus genera, which was consistent with the functional gene predictive analysis and is believed to have health-promoting properties. Based on these results, our novel strain is considered a safe and good probiotic and could hold high potential to be used as a starter culture or to safely supplement functional foods as a probiotic and may provide new insights into therapeutic interventions.

Keywords: Lactiplantibacillus plantarum; antioxidants; cholesterol-lowering; gut microbiota; hemolytic activity; probiotic; virulence genes.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactiplantibacillus plantarum KABP™-022Enhanced Auto-aggregation AbilityBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Enhanced Co-aggregation AbilityBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Improved Acid ToleranceBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Improved Tolerance to Bile SaltsBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Increased Antioxidant ActivityBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Increased Antipathogen Activity Against Escherichia coliBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Increased Antipathogen Activity Against Staphylococcus AureusBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Increased Short-Chain Fatty Acid ProductionBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Modulated Gut Microbial DiversityBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022No HemolysisBeneficial
Large
Lactiplantibacillus plantarum KABP™-022Reduced Cholesterol LevelsBeneficial
Moderate
Lactiplantibacillus plantarum KABP™-022Reduced Total Cholesterol LevelsBeneficial
Moderate
Back to top